Section 4: Clinical Pharmacy Services 2020
DOI: 10.1136/ejhpharm-2020-eahpconf.160
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-059 Strategy for change in antiretroviral therapy: looking for better results

Abstract: in 52% was 5 days. Seventy-three patients received empiric levofloxacin, 67 ceftriaxone, 35 amoxicillin/clavulanic and 11.8% received no antibiotic. Conclusion and relevance PCR was not performed in all patients suspected of flu virus infection. The population >65 years of age was the most affected by the virus, with HTA and smoking being the main risk factors. Oseltamivir was used at the correct dose, but treatment duration greater than or less than 5 days was not warranted. Adjustment for CKD was not always … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles